Enrichment analysis of pathways from the GSVA website revealed that CD73 participated in the activation of several immune-related pathways in most cancers, such as BLCA, BRCA, LUAD, LUSC, OV, and PRAD (Figure 4A). This evidence concerns the gene NT5E and cancer.